An audit of the antithrombotic therapy for the management of valve repair or replacement Gellatly RM 1,2, Maydelmin D 1, Connell C 1, Marasco S 3, Zimmet.
SILEN-C2: sustained virological response (SVR) and safety of BI 201335 combined with peginterferon alfa 2a and ribavirin (PegIFN/RBV) in chronic HCV genotype-1.
Effects of Clinical Characteristics and Treatments on Gender Difference in Outcomes after Acute Myocardial Infarction. A propensity score-matched analysis.
PRIMA-study main outcome ACC Orlando March 2009 NT-proBNP guided management of chronic heart failure based on an individual target value PRIMA-study Luc.
The ENCORE Study Cardiovascular Benefits Associated With the DASH Diet Alone and in Combination with Exercise and Weight Reduction in Men and Women with.
The SOS (Stenting Of Saphenous vein grafts) Randomized, Controlled Trial of a Paclitaxel-Eluting Stent Vs. a Similar Bare Metal Stent in Saphenous Vein.
Prospective, Randomized Trial of Paclitaxel- versus Sirolimus- Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents Robert A.
Prepared by: ACTION Registry-GWTG Results: January – December, 2008.
A Prospective, Randomized Comparison of Bivalirudin vs. Heparin Plus Glycoprotein IIb/IIIa Inhibitors During Primary Angioplasty in Acute Myocardial Infarction.
Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano 9 - 10 aprile 2010 ICD data.
Correcting for Selection Bias in Randomized Clinical Trials Vance W. Berger, NCI 9/15/05 FDA/Industry Workshop, DC.
Engaging Patients in Guided Care Chad Boult, MD, MPH, MBA Professor of Public Health, Medicine and Nursing Johns Hopkins University Alliance for Health.
